Lopressor Hct
NDC Package 30698-461-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Lopressor Hct is indicated for the management of hypertension.This fixed-combination drug is not indicated for initial therapy of hypertension. Marketed by Validus Pharmaceuticals Llc, this product is identified by NDC 30698-461 and is authorized under FDA application NDA018303.

Identification & Billing

NDC Package Code
30698-461-01
Package Description
100 TABLET in 1 BOTTLE
Product Code
30698-461
11-Digit Billing Format
30698046101
RxNorm Crosswalk
  • RxCUI: 866479 - metoprolol tartrate 100 MG / hydroCHLOROthiazide 25 MG Oral Tablet
  • RxCUI: 866479 - hydrochlorothiazide 25 MG / metoprolol tartrate 100 MG Oral Tablet
  • RxCUI: 866479 - HCTZ 25 MG / metoprolol tartrate 100 MG Oral Tablet
  • RxCUI: 866482 - metoprolol tartrate 50 MG / hydroCHLOROthiazide 25 MG Oral Tablet
  • RxCUI: 866482 - hydrochlorothiazide 25 MG / metoprolol tartrate 50 MG Oral Tablet

Clinical Specifications

Proprietary Name
Lopressor Hct
Dosage Form
-
Usage Information
Lopressor HCT is indicated for the management of hypertension.This fixed-combination drug is not indicated for initial therapy of hypertension. If the fixed combination represents the dose titrated to the individual patient's needs, therapy with the fixed combination may be more convenient than with the separate components.

Regulatory & Marketing

Labeler Name
Validus Pharmaceuticals Llc
FDA Application #
NDA018303
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
06-30-2014
Listing Expiration
12-31-2025
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 30698-461-01 identifies a specific commercial package of 100 tablet in 1 bottle of Lopressor Hct, labeled by Validus Pharmaceuticals Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Validus Pharmaceuticals Llc on June 30, 2014. The current certification is valid through December 31, 2025.

How is this Validus Pharmaceuticals Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 30698046101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
30698-461-01
11-Digit CMS (5-4-2)
30698-0461-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.